Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of Molecular Biomarkers, Including microRNAs and Metabolites, Enabling Early Differentiation of Parkinson's Disease and Atypical Parkinsonian Syndromes in a Prospective Observational Study.

NCT07604883 is registered in ClinicalTrials.gov with International Institute of Molecular and Cell Biology in Warsaw as lead sponsor.

NCT NCT07604883
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07604883 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of Molecular Biomarkers, Including microRNAs and Metabolites, Enabling Early Differentiation of Parkinson's Disease and Atypical Parkinsonian Syndromes in a Prospective Observational Study.
Lead sponsor
International Institute of Molecular and Cell Biology in Warsaw
Phase
Observational
Overall status
Not yet recruiting
Start date
June 4, 2026
Completion date
June 4, 2029
Enrollment
200 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

atypical parkinsonism, dementia with lewy bodies (dlb), multiple system atrophy, parkinson disease (disorder), progressive supranuclear palsy (psp)